The MGMT promoter SNP rs16906252 is a risk factor for MGMT methylation in glioblastoma and is predictive of response to temozolomide
about
Clinical Neuropathology practice guide 5-2015: MGMT methylation pyrosequencing in glioblastoma: unresolved issues and open questionsCIViC databaseThe prognostic value of MGMT promoter status by pyrosequencing assay for glioblastoma patients' survival: a meta-analysisThe rs16906252:C>T SNP is not associated with increased overall survival or temozolomide response in a Han-Chinese glioma cohort.Assessment of Quantitative and Allelic MGMT Methylation Patterns as a Prognostic Marker in GlioblastomaVeliparib in combination with radiotherapy for the treatment of MGMT unmethylated glioblastoma.Melanocortin Receptor-4 Gene Polymorphisms in Glioblastoma Patients Treated with Concomitant Radio-Chemotherapy.Epigenetic alternations and cancer chemotherapy response.DNA methylation in adult diffuse gliomas.Toward Personalized Targeted Therapeutics: An Overview.Cancer subtypes in aetiological research.SNP rs16906252C>T Is an Expression and Methylation Quantitative Trait Locus Associated with an Increased Risk of Developing MGMT-Methylated Colorectal Cancer.Relationship between MGMT gene expression and treatment effectiveness and prognosis in glioma.The tumoral A genotype of the MGMT rs34180180 single-nucleotide polymorphism in aggressive gliomas is associated with shorter patients' survival.The MGMT promoter single-nucleotide polymorphism rs1625649 had prognostic impact on patients with MGMT methylated glioblastoma.Clinical Applications of Contrast-Enhanced Perfusion MRI Techniques in Gliomas: Recent Advances and Current Challenges.Association of Glutathione S-Transferase P-1 (GSTP-1) rs1695 polymorphism with overall survival in glioblastoma patients treated with combined radio-chemotherapy.The Clinical Significance of O6-Methylguanine-DNA Methyltransferase Promoter Methylation Status in Adult Patients With Glioblastoma: A Meta-analysis.A systematic review and meta-analysis of topoisomerase inhibition in pre-clinical glioma models.
P2860
Q26795767-ED3D975F-5FE2-4FC2-BB82-60557BBEFC8FQ27612411-C7E457C5-EE07-4CD4-ABF6-A764808EE486Q28074595-39825D44-1048-401F-80EC-063508CC6ED3Q33757960-2E291CE3-9E31-4268-BDDB-26AAF31753D1Q36648767-EA0A2176-B2ED-4A0A-BCCC-1F358D12BC68Q37708325-8F03796D-8F54-4F41-9524-355B2EEBC691Q38381406-D487307F-34C4-493B-93F8-80FE15ACC94CQ38680431-625CB9D8-146D-4BED-8160-4E04545C6C53Q38861997-0552D6B6-3C94-4B33-A233-0D9E6D4E5254Q39044141-7BC5AA4C-5209-4772-9185-B467AF4DBAC8Q39397286-9F82D2CB-7457-46E9-97E0-1AC9DED671B5Q40716298-F528BC8E-A6C1-473F-8C32-C33603C76111Q40978153-A1631246-B7A4-404F-8FB9-039A4C93DEBDQ41009177-6B01A162-1227-4A7F-B845-898360243A47Q42696213-E2A38790-356A-4769-B4BE-5F20B2DDD43CQ43376098-890879FE-7669-4451-A9FB-BAE05A7E2F27Q48089892-F72AEFB0-1759-450F-BEDF-6F7EE5A54BFBQ52606179-6C66F841-8EF2-407A-AC21-24830150213DQ52655032-F8B5EA32-351A-42EB-8549-AF0B450263A4
P2860
The MGMT promoter SNP rs16906252 is a risk factor for MGMT methylation in glioblastoma and is predictive of response to temozolomide
description
2015 nî lūn-bûn
@nan
2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
The MGMT promoter SNP rs169062 ...... ve of response to temozolomide
@ast
The MGMT promoter SNP rs169062 ...... ve of response to temozolomide
@en
The MGMT promoter SNP rs169062 ...... e of response to temozolomide.
@nl
type
label
The MGMT promoter SNP rs169062 ...... ve of response to temozolomide
@ast
The MGMT promoter SNP rs169062 ...... ve of response to temozolomide
@en
The MGMT promoter SNP rs169062 ...... e of response to temozolomide.
@nl
altLabel
The MGMT promoter SNP rs169062 ...... ve of response to temozolomide
@en
prefLabel
The MGMT promoter SNP rs169062 ...... ve of response to temozolomide
@ast
The MGMT promoter SNP rs169062 ...... ve of response to temozolomide
@en
The MGMT promoter SNP rs169062 ...... e of response to temozolomide.
@nl
P2093
P2860
P3181
P356
P1433
P1476
The MGMT promoter SNP rs169062 ...... ve of response to temozolomide
@en
P2093
Albert Lai
HuyTram N Nguyen
Kerrie L McDonald
Megan P Hitchins
Robert W Rapkins
Timothy F Cloughesy
P2860
P304
P3181
P356
10.1093/NEUONC/NOV064
P577
2015-04-24T00:00:00Z